PA and 4D Biomedical’s report on Academic health social networks (AHSN) is detailed in Pharma Times magazine.
The article quotes from PA’s report which explains that the life sciences industry and the NHS need to overcome their cultural mismatch and find ways to work together if AHSNs are to flourish.
PA explains: “Until recently, the NHS has been ‘anti-wealth’ and continues to be in parts, while industry usually needs to achieve significant revenues and profits within a defined and limited timeframe, which is often shorter than the timescales the NHS can move from innovation to commercial adoption.”
PA goes on to explain that the NHS is strongly focussed on patient care and patient outcomes but the industry looks at outcomes balanced with the financial implications: “Industry is always going to look at what it needs to do to ‘protect’ its investment from competitors, leading to distortions and complications where the NHS will not see or want such complications introduced.”
The article goes on to quote PA’s report which says that AHSNs are vital for the future of healthcare in the UK but their success is far from certain because of a number of obstacles. The report also states that the networks need tens – if not hundreds – of millions of pounds to really create meaningful wealth, yet they have budgets of £2 – £5 million per annum.
PA concludes by explaining that the networks stand a real chance of cutting the time between ‘bench and patient’, and making innovation happen in the UK, despite the significant cultural and organisational challenges.